
this drawing doesn’t relate to anything in this newsletter. just wanted to doodle something.
"När jag tvivlar skyller jag på andra" = "When I doubt, I blame others"
the market is back in "pop" territory! this is an exciting place to be.
not "pop goes the weasel" "pop," but "pop" as in pop music/culture.
"pop" as in investors are comfortable in their unknowing and/or at least think they know what comes next.
when listening to pop music, what comes next is generally always knowable. consciously observerved or not, your brain understands what's going on with the structure, the choice of chords, the rhythm, &c.
even if it's a sad pop song, it's probably predictably predictable.
markets love when predictable outcomes follow an anticipated impetus, even if the specifics remain unknown in advance.
there are still some relevant earnings to go through, but unless any are overpowering bearish whoppers, we've cleared enough significant hurdles to get us to $NVDA reporting on August 26th, at least.
everything we own / care about has already reported, so we're not following any of the following earnings too closely. but we've circled some of the ones we think The Market cares about most. anything that provides more color on hyperscaler capex, semiconductor/memory demand, consumer resilience is still relevant. but like we said earlier, markets may be more willing to write off negatives now than in the recent past.
that's the joy of psychology. even if nothing changes, things can still change. internal representations of reality shifting en masse can replace an unstable reality with a familiar-seeming, stable one. or vice versa.

shared.image.missing_image
to investors: inflation data was fine, jobs data was fine, rate hike odds are down, Treasury yields is fine, the earnings that mattered most were mostly fantastic, &c
the interrim silence between notable events/TACOs/disasters/reprieves no longer feels painful to sit with.
in other words, investors are generally comfortable with what they know + don't know.
contrast that with the previous few weeks (months?), where (in our view) a prolonged, irreconcilable unease that couldn't be remedied plagued markets—headwinds, one might say, but more psychological in nature than usual.
we're firmly in a long-term technological uptrend, but markets LOVE to front-run technological progress, so: it won't be smooth sailing while (as-observed-by-the-majority) "AI progress" slows, and if growth of growth of progress falters, look out below.
investors invest in the future, in the second-order derivative of earnings—growth of growth. if growth slows versus what's already priced in, even if the face-value, present-moment results remain blindingly positive, investors start to pare back their enthusiasm. and that's domino #1.
the differences this time around:
every time progress seems to slow, it re-accelerates (significant step-wise model upgrade, new (speculative) exciting application for AI, new AI-powered scientific breakthrough, the entire landscape of war/defense gets changed by AI...
full-stack government backing of the most complex & high-level AI applications (see: DoW/DoD) all the way down to the individual materials that need to be mined. that includes manufacturing hardware, compute power, energy infrastructure, processing equipment, testing equipment, specialized materials & chemicals, a workforce to tend to the glorious trickle down autonomy new industrial complex.
by several measures (trading activity, capital deployment, and options activity), retail plays a larger role than it ever has, and retail wasn't a major player during previous broad tech bubbles. and their "stupidity" keeps paying off! the median investor spends six whole minutes before FOMO-ing into something up 500% YTD that their friend drunkenly recommended over a few beers. is it stupidity, or is it an ingrained, subconscious awareness that investing in the US stock market always pays off over some time frame? when the crypto bubble burst, it took retail down with it. guess who was back to investing in AI the moment their next paycheck hit? there's also certainly an aspect of "if this stock doesn't go up 10,000%, i'll never be able to afford a house." interviews with retail investors have provided evidence of the coexistance of both the "stocks will eventually go up again" and the "i'll never get a house, so i'm putting all my money in stocks" strategies, which are not mutually exclusive!
attention hopped from key event to key event, as it tends to do, but each of the anticipated-to-be-bullish events largely turned out to be ointment to temporarily soothe bug bites, not the Bawls energy-boosting rally fuel many hoped.
profit-taking opportunities!
the difference between this and different market corrections was the lack of novel stimulus, in our opinion.
it all felt as though we were stuck in an eternal waiting room, not to see a doctor, but to get handed a wad of cash…
"wow, i can't wait to get handed some dosh!"
then time passes. the clock audibly ticks its thousandth or hundred-thousandth tick.
you're told the payout is coming, but maybe you were tricked? but wait, the data supports your belief that you're at the Money Payout Office.
more time passes, and other people are getting up and leaving now!
maybe you read the sign on the front door wrong. you get up and go re-read it. as before, it says "Money Payout Office."
some random guy name Leopold gets up from his seat and goes into the back room. he comes out, sad, but says to everyone sitting around looking depressed—looking depressed in the MONEY PAYOUT OFFICE, for pete's sake....
he says: "i re-stocked the vault. it didn't need re-stocking, but i re-stocked it anyway. if you all could see the Scrooge McDuck-levels of wealth concentrated in that one place, you'd all lose your minds... anyway, it's re-stocked. i, Leopold, re-stocked the reserves of the Money Payout Office. enjoy."
everyone is smiling again. the silence remains deafening as ever, but everyone got confirmation the vault is LOADED, so their time is occupied fantasizing about things money can buy. they're no longer questioning the the Money Payout Office's credibility, let alone its existence.
WHAT WE'RE WATCHING
1.) when nothing is happening and markets are relatively quiet, which way are relevant indices/stocks/sectors drifting? that can help provide a gauge of "Payout Office" anxiety. are investors comfortable sitting and waiting for money to come to them?
2.) tech stocks, the Nasdaq especially, need to return to highs before the next correction. the DOW, S&P 500, and Russell 2000 all put in new highs since July's market low. the Nasdaq has not.

shared.image.missing_image
3.) if the ongoing, gradual, two-steps-forward/one-step-back rotation out of crowded AI stocks into other themes leads to middle-of-the-road performance for the AI complex, can the market latch onto a new dominant narrative and continue trudging higher?
the worst-case scenario is AI stocks losing too many dollars and losing too much of its "elephant in the room" power for bullish reasons. one cannot simply stop being an elephant when elephants stop being in vogue. the best-case scenario would be broad market strength even alongside relative AI weakness. that's sort of what we're seeing now, with superior strength in biotech/space/software/commodities & individual AI companies. that's healthy. let the narrative slowly shift further out on the AI adjacency matrix. we've already made the jump from GPUs to (skipping a few steps) energy infrastructure. a possible next evolution of the "AI narrative" (which enables a more seamless, orderly transition in market leadership) could include loose "AI appliers," which, could be basically any company. if Ryanair can announce they're jointly leveraging Google Cloud and AWS to effectively and resiliently optimize operations, anyone can do this whole AI thing.
we've seen a lot of companies spending on AI, the benefits are only slowly materializing, and they could materialize anywhere! we're not saying it'd make sense for the AI narrative to remain the bull market's vessel forever, but it's easier than convincing the market to 1.) be more excited about something else, and 2.) not panic sell their current slate of aging AI stocks. (the issue is not the stocks, it's the valuations, which, as explained earlier, ride on expectations of exceeding future expectation.)
4.) on-site energy infrastructure stocks. as midterms approach, we anticipate more money should continue to flow into the companies enabling power generation with different regulatory and logistic hurdles, as data center hate remains problematic (for data centers).
stocks like BE, FCEL, EROC, the lattermost of which is up >30% post-earnings after the Texas-based company reported sky-high demand for its distributed energy generation systems: system sales backlog up 10x to $1.7 billion due to AI data center demand, 470 megawatt purchase order with Anthropic, notable construction starts, and $626.6 million in cash. we don't own any of these, but we're keeping tabs on them.
if we hit (temporarily) rough waters in a few weeks, after the current familiarity subsides, we'll see if any look good to us then.
we'll conclude with a chart showing performance of some thematic ETFs since July 30:
shared.image.missing_image

NASA: space
ARKG: genomics-heavy biotech
URA/URNM: uranium / uranium miners
IGV: software
SMH: chips
XBI: biotech
XLV: healthcare
OILK: oil futures
one interesting thing we noticed is the concentrated biotech ETF outperforming the broader biotech ETF, which outperformed a flatlining healthcare ETF. ARKG has 33 holdings compared to XBI's 157, so individual stock moves have a larger impact on overall performance. TWST, a fav of ours (and responsible for an outsized portion of our performance recently), is ARKG’s second-largest holding.
PORTFOLIO/WATCHLIST NEWS
Q2 revenue up 454% to 582.3M, adjusted EBITDA of 236.2M & GAAP continuing-operations loss of $190.4M
four AI-cloud deals averaged more than $1B in contract value, with roughly 70% carrying prepayments covering 50–60% of associated capex
year-end contracted-power guidance raised to 5 GW, with plans to deploy more than 1 GW annually from 2027
Q2 property-and-equipment purchases reached $5.66B
record Q2 revenue up 62% to 234M, backlog up 137% to 2.36B, Q3 revenue guidance of 250–265M & more than 437M of launch contracts secured across Q2 and subsequent signings
Neutron remains scheduled for Q4 delivery to the launchpad, though the 2026 first-launch window is narrowing
dedicated Neutron launch for Kepler no sooner than 2028
established Rocket Lab Germany to pursue European commercial & sovereign space work, with possible future satellite and component manufacturing in Germany
announced GHOST deployable launch system. first two pads will be in Kodiak, Alaska, with an operational debut planned for 2027
received a $28M DARPA contract extension to develop manufacturing capacity & deliver 25 Evergreen-05 optical atomic clocks
unexercised 30M option covers another 100 clocks, bringing potential contract value to 58M
plans to invest $15M in clock production capacity
Capella subsidiary won an NRO contract to supply commercial synthetic-aperture-radar imagery. value undisclosed
received a $780,000 order from a new defense prime for edge AI threat-mapping hardware & Blue UAS drones, with work expected through Q1 2027
2026 AI-related order awards surpassed $5M across eight contracts
signed a CRADA with the U.S. Army ERDC covering drone imagery, object detection & geospatial products for military, disaster-response & civil-engineering work
Q2 revenue up 23% to a record 2.2B, adjusted EBIT of 296.9M, 13.3% adjusted EBIT margin & $401M adjusted free cash flow excluding Eve
full-year adjusted EBIT-margin guidance raised from 8.7–9.3% to 10–10.6%; minimum free-cash-flow guidance doubled to $400M
delivered 65 aircraft, its strongest Q2 in 16 years; backlog remained at a record $34.5B
results included a $68M extraordinary tax credit. adjusted EBIT margin excluding the credit & tariff effects was 10.6%
named its coming midsize electric pickup Fathom, with a $28,350 base price before destination
Fathom will use Ford’s Universal Electric Vehicle platform & new assembly-tree process in Louisville
preorders planned for early 2027, with deliveries expected that autumn
plans to move some Lincoln production from China to the US beginning in 2030. factory location & investment were undisclosed
UK approved once-daily oral orforglipron, branded Foundayo, for weight management & insufficiently controlled type 2 diabetes
NHS access still requires NICE review
filed six US lawsuits against sellers of unapproved retatrutide products
reported more than 14,000 illegal retatrutide listings across over 100 countries. retatrutide remains investigational
Q2 revenue up 46% to 24.1M, ACV plus royalties up 44% to 99.5M, RPO up 36% to $135M & trailing royalty revenue up 65%
customer-confirmed design starts up 21%
quarterly free cash flow of 8.6M, while GAAP operating loss widened to 13.9M
full-year guidance calls for 95–98M revenue & 5–9M free cash flow
Saurabh Sinha becomes CFO on september 8
SpaceMD booked its first commercial SpaceX Starfall mission, planned for 2028 with capacity for up to 32 pharmaceutical PIL-BOX experiments
signed a teaming agreement with Kanematsu covering Japanese business development for power systems, microgravity payloads & robotics
neither agreement disclosed contract value or committed customer volume
CellCarta added Tempus as the second commercial laboratory in its companion-diagnostic network
Tempus Hub will handle provider ordering, sample routing & result delivery for CellCarta’s oncology CDx programs
no economics or test-volume commitments disclosed
THE REST
we had a lot of articles, research, videos, & other media to get through this week that we thought would be interesting to share, but we didn’t get around to it...
we've been focusing more on health & creativity/art.
when markets get rocky again, we'll pay more attention to them again, but for now we're comfortable with our holdings & strategy.
also, we're still trying to figure out what the heck Chunky does. (ie. what we want to write about, how we want to write about it, &c.)
a cool thing about this song is that the band, Operating Theatre, leveraged one of the first "Computer Music Instruments" that enabled the electronic music genre & "sampling." Bono read Operating Theatre's creator mention his magical computer in an interview and ultimmately ended up helping produce the song above.
Wikipedia says the first series was used by: Peter Gabriel, Led Zeppelin, Boz Burrell, Kate Bush, Geoff Downes, Trevor Horn, Alan Parsons, Richard Wright, Thomas Dolby, Stevie Wonder, Herbie Hancock, Jan Hammer, Todd Rundgren and Joni Mitchell.
technology (computer) finds a way (to augment an artist).
see you next time.
AURUM NOSTRUM NON EST AURUM VULGI 🪱
